EBS

SEC source: 0001367644-23-000059 · wf-form4_167778619560344.xml · nonDerivative · entry 1

Williams Paul Anthony · CIK 0001961994 · SVP, Products Business

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,916

F1 · shares: Represents shares of common stock withheld to pay taxes.

SEC source: 0001367644-23-000058 · wf-form4_167778617847267.xml · nonDerivative · entry 1

SARAN ATUL · CIK 0001591070 · EVP, Chief Strat & Dev Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,645

F1 · shares: Represents shares of common stock withheld to pay taxes.

SEC source: 0001367644-23-000055 · wf-form4_167778610693108.xml · nonDerivative · entry 1

Kramer Robert · CIK 0001380956 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,298

F1 · shares: Represents shares of common stock withheld to pay taxes.

SEC source: 0001367644-23-000054 · wf-form4_167778608843186.xml · nonDerivative · entry 1

Havey Adam · CIK 0001514588 · EVP, Business Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,927

F1 · shares: Represents shares of common stock withheld by the Company in exchange for payment of the employee's withholding taxes.

SEC source: 0001367644-23-000034 · wf-form4_167754734539183.xml · nonDerivative · entry 2

Fox Jennifer Lynne · CIK 0001914879 · EVP, Ext Aff, GC, Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,902

F1 · shares: Represents shares of common stock withheld to pay taxes.

SEC source: 0001367644-23-000038 · wf-form4_167754742435549.xml · nonDerivative · entry 2

Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,514

F1 · shares: Represents shares of common stock withheld to pay taxes.

SEC source: 0001367644-23-000035 · wf-form4_167754736499121.xml · nonDerivative · entry 2

LINDAHL RICHARD S · CIK 0001196632 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,980

F1 · shares: Represents shares of common stock withheld to pay taxes.

SEC source: 0001367644-23-000037 · wf-form4_167754740191933.xml · nonDerivative · entry 2

SARAN ATUL · CIK 0001591070 · EVP, Chief Strat & Dev Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,616

F1 · shares: Represents shares of common stock withheld to pay taxes.

SEC source: 0001367644-23-000033 · wf-form4_167754732777822.xml · nonDerivative · entry 2

Havey Adam · CIK 0001514588 · EVP, Business Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,681

F1 · shares: Represents shares of common stock withheld to pay taxes.

SEC source: 0001367644-23-000032 · wf-form4_167754730066296.xml · nonDerivative · entry 2

Kramer Robert · CIK 0001380956 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 106,524

F1 · shares: Represents shares of common stock withheld to pay taxes.

SEC source: 0001367644-23-000034 · wf-form4_167754734539183.xml · nonDerivative · entry 1

Fox Jennifer Lynne · CIK 0001914879 · EVP, Ext Aff, GC, Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,160

F1 · shares: Represents shares of common stock withheld to pay taxes.

SEC source: 0001367644-23-000038 · wf-form4_167754742435549.xml · nonDerivative · entry 1

Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,168

F1 · shares: Represents shares of common stock withheld to pay taxes.

SEC source: 0001367644-23-000035 · wf-form4_167754736499121.xml · nonDerivative · entry 1

LINDAHL RICHARD S · CIK 0001196632 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,957

F1 · shares: Represents shares of common stock withheld to pay taxes.

SEC source: 0001367644-23-000037 · wf-form4_167754740191933.xml · nonDerivative · entry 1

SARAN ATUL · CIK 0001591070 · EVP, Chief Strat & Dev Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,461

F1 · shares: Represents shares of common stock withheld to pay taxes.

SEC source: 0001367644-23-000036 · wf-form4_167754738229834.xml · nonDerivative · entry 1

Williams Paul Anthony · CIK 0001961994 · SVP, Products Business

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,287

F1 · shares: Represents shares of common stock withheld to pay taxes.

SEC source: 0001367644-23-000033 · wf-form4_167754732777822.xml · nonDerivative · entry 1

Havey Adam · CIK 0001514588 · EVP, Business Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,493

F1 · shares: Represents shares of common stock withheld to pay taxes.

SEC source: 0001367644-23-000032 · wf-form4_167754730066296.xml · nonDerivative · entry 1

Kramer Robert · CIK 0001380956 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 108,115

F1 · shares: Represents shares of common stock withheld to pay taxes.

SEC source: 0001367644-23-000016 · wf-form4_167607932918775.xml · nonDerivative · entry 2

Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,520

F2 · shares: Represents shares of common stock withheld to pay taxes.

SEC source: 0001367644-23-000016 · wf-form4_167607932918775.xml · nonDerivative · entry 1

Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,958

F1 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2022 fiscal year, as certified by the Compensation Committee following the performance period. On February 08, 2023, the final certification date, the Compensation Committee certified the achievement of the 2020-2022 PSUs at a payout factor of 101.67% of target resulting in the actual award of 3,723 shares of common stock, which is in excess of the 3,662 shares previously reported on February 25, 2020.

SEC source: 0001367644-23-000014 · wf-form4_167607927638617.xml · nonDerivative · entry 2

LINDAHL RICHARD S · CIK 0001196632 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,401

F2 · kind: Represents shares of common stock withheld to pay taxes.

SEC source: 0001367644-23-000014 · wf-form4_167607927638617.xml · nonDerivative · entry 1

LINDAHL RICHARD S · CIK 0001196632 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,797

F1 · kind: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2022 fiscal year, as certified by the Compensation Committee following the performance period. On February 08, 2023, the final certification date, the Compensation Committee certified the achievement of the 2020-2022 PSUs at a payout factor of 101.67% of target resulting in the actual award of 6,205 shares of common stock, which is in excess of the 6,104 shares previously reported on February 25, 2020.

SEC source: 0001367644-23-000017 · wf-form4_167607935092887.xml · nonDerivative · entry 2

Kramer Robert · CIK 0001380956 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,543

F2 · shares: Represents shares of common stock withheld to pay taxes.

SEC source: 0001367644-23-000017 · wf-form4_167607935092887.xml · nonDerivative · entry 1

Kramer Robert · CIK 0001380956 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 114,487

F1 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2022 fiscal year, as certified by the Compensation Committee following the performance period. On February 08, 2023, the final certification date, the Compensation Committee certified the achievement of the 2020-2022 PSUs at a payout factor of 101.67% of target resulting in the actual award of 16,961 shares of common stock, which is in excess of the 16,683 shares previously reported on February 25, 2020.

SEC source: 0001367644-23-000015 · wf-form4_167607930892087.xml · nonDerivative · entry 2

SARAN ATUL · CIK 0001591070 · EVP, Chief Strat & Dev Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,826

F2 · shares: Represents shares of common stock withheld to pay taxes.

SEC source: 0001367644-23-000015 · wf-form4_167607930892087.xml · nonDerivative · entry 1

SARAN ATUL · CIK 0001591070 · EVP, Chief Strat & Dev Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,877

F1 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2022 fiscal year, as certified by the Compensation Committee following the performance period. On February 08, 2023, the final certification date, the Compensation Committee certified the achievement of the 2020-2022 PSUs at a payout factor of 101.67% of target resulting in the actual award of 5,792 shares of common stock, which is in excess of the 5,697 shares previously reported on February 25, 2020.

SEC source: 0001367644-23-000013 · wf-form4_167607925563475.xml · nonDerivative · entry 2

Havey Adam · CIK 0001514588 · EVP, Business Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,925

F2 · shares: Represents shares of common stock withheld to pay taxes.

SEC source: 0001367644-23-000013 · wf-form4_167607925563475.xml · nonDerivative · entry 1

Havey Adam · CIK 0001514588 · EVP, Business Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,889

F1 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2022 fiscal year, as certified by the Compensation Committee following the performance period. On February 08, 2023, the final certification date, the Compensation Committee certified the achievement of the 2020-2022 PSUs at a payout factor of 101.67% of target resulting in the actual award of 5,792 shares of common stock, which is in excess of the 5,697 shares previously reported on February 25, 2020.

SEC source: 0001367644-22-000155 · wf-form4_167096987928470.xml · nonDerivative · entry 2

Fox Jennifer Lynne · CIK 0001914879 · EVP, Ext Aff, GC, Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,391

F2 · shares: Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in one annual installment beginning on the day prior to the second anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.

SEC source: 0001367644-22-000155 · wf-form4_167096987928470.xml · nonDerivative · entry 1

Fox Jennifer Lynne · CIK 0001914879 · EVP, Ext Aff, GC, Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,256

F1 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2022 and ending December 31, 2024, as certified by the Compensation Committee following the performance period. The amount reported is based on the target performance payout factor, or 100%.

SEC source: 0001367644-22-000156 · wf-form4_167096997706667.xml · nonDerivative · entry 2

Glessner Coleen · CIK 0001919170 · EVP, Quality & Ethics, and CPL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 108,136

F2 · shares: Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in one annual installment beginning on the day prior to the second anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.

SEC source: 0001367644-22-000156 · wf-form4_167096997706667.xml · nonDerivative · entry 1

Glessner Coleen · CIK 0001919170 · EVP, Quality & Ethics, and CPL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,904

F1 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2022 and ending December 31, 2024, as certified by the Compensation Committee following the performance period. The amount reported is based on the target performance payout factor, or 100%.

SEC source: 0001367644-22-000148 · wf-form4_166975354620077.xml · nonDerivative · entry 1

Richard Ronald · CIK 0001380177 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,837

F1 · security: Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated.

SEC source: 0001367644-22-000146 · wf-form4_166854681352678.xml · nonDerivative · entry 1

Fox Jennifer Lynne · CIK 0001914879 · EVP, Ext Aff, GC, Corp Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,211

F1 · shares: Represents shares of common stock of Emergent BioSolutions Inc withheld to pay tax liability on shares of restricted stock awarded pursuant to Rule 16b-3(d), which vested on November 11, 2022.

SEC source: 0001367644-22-000109 · wf-form4_165852098632017.xml · nonDerivative · entry 1

Dayal Sujata Tyagi · CIK 0001536908 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,852

F1 · shares: Consists of restricted stock units granted under the company's Stock Incentive Plan, as amended and restated. These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.

SEC source: 0001367644-22-000101 · wf-form4_165515135039033.xml · nonDerivative · entry 1

Zoon Kathryn C · CIK 0001685720 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,654

F1 · security: Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated.

SEC source: 0001367644-22-000088 · wf-form4_165402799025784.xml · nonDerivative · entry 1

Zoon Kathryn C · CIK 0001685720 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,827

F1 · security: Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated.

F2 · shares: These restricted stock units vest in three equal annual installments beginning on the earlier of: (i) the day prior to the first anniversary of the date of grant, or (ii) the day prior to annual shareholder meeting; assuming continued service with the company.

SEC source: 0001367644-22-000091 · wf-form4_165402831199670.xml · nonDerivative · entry 1

White Marvin L · CIK 0001493324 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,102

F1 · security: Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated.

F2 · shares: These restricted stock units vest in three equal annual installments beginning on the earlier of: (i) the day prior to the first anniversary of the date of grant, or (ii) the day prior to annual shareholder meeting; assuming continued service with the company.

SEC source: 0001367644-22-000093 · wf-form4_165402855664092.xml · nonDerivative · entry 1

Hauer Jerome M · CIK 0001294935 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,661

F1 · security: Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated.

F2 · shares: These restricted stock units vest in three equal annual installments beginning on the earlier of: (i) the day prior to the first anniversary of the date of grant, or (ii) the day prior to annual shareholder meeting; assuming continued service with the company.

SEC source: 0001367644-22-000092 · wf-form4_165402841193936.xml · nonDerivative · entry 1

JOULWAN GEORGE A · CIK 0001222197 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,244

F1 · security: Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated.

F2 · shares: These restricted stock units vest in three equal annual installments beginning on the earlier of: (i) the day prior to the first anniversary of the date of grant, or (ii) the day prior to annual shareholder meeting; assuming continued service with the company.

SEC source: 0001367644-22-000089 · wf-form4_165402808228714.xml · nonDerivative · entry 1

SULLIVAN LOUIS W · CIK 0001193522 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,418

F1 · security: Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated.

F2 · shares: These restricted stock units vest in three equal annual installments beginning on the earlier of: (i) the day prior to the first anniversary of the date of grant, or (ii) the day prior to annual shareholder meeting; assuming continued service with the company.

SEC source: 0001367644-22-000094 · wf-form4_165402866909554.xml · nonDerivative · entry 1

Harsanyi Zsolt · CIK 0001380184 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,052

F1 · security: Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated.

F2 · shares: These restricted stock units vest in three equal annual installments beginning on the earlier of: (i) the day prior to the first anniversary of the date of grant, or (ii) the day prior to annual shareholder meeting; assuming continued service with the company.

SEC source: 0001367644-22-000090 · wf-form4_165402821355835.xml · nonDerivative · entry 1

Richard Ronald · CIK 0001380177 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,749

F1 · security: Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated.

F2 · shares: These restricted stock units vest in three equal annual installments beginning on the earlier of: (i) the day prior to the first anniversary of the date of grant, or (ii) the day prior to annual shareholder meeting; assuming continued service with the company.

SEC source: 0001367644-22-000077 · wf-form4_165350953758392.xml · nonDerivative · entry 1

Zoon Kathryn C · CIK 0001685720 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,381

F1 · security: Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated.

F2 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended.

SEC source: 0001367644-22-000063 · wf-form4_164979397671420.xml · derivative · entry 3

Glessner Coleen · CIK 0001919170 · EVP, Quality & Ethics, and CPL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,651

Underlying: Common Stock · 23,651 shares

Expires 2029-04-07

F3 · derivative.exercise_date: Vests in three equal installments beginning on the day prior to the anniversary date of the grant.

SEC source: 0001367644-22-000063 · wf-form4_164979397671420.xml · nonDerivative · entry 2

Glessner Coleen · CIK 0001919170 · EVP, Quality & Ethics, and CPL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,826

F2 · shares: Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.

SEC source: 0001367644-22-000063 · wf-form4_164979397671420.xml · nonDerivative · entry 1

Glessner Coleen · CIK 0001919170 · EVP, Quality & Ethics, and CPL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,913

F1 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2022 and ending December 31, 2024, as certified by the Compensation Committee following the performance period. The amount reported is based on the target performance payout factor, or 100%.

SEC source: 0001367644-22-000061 · wf-form4_164919014507684.xml · nonDerivative · entry 1

Katkin Keith · CIK 0001314596 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,595

F1 · shares: Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.

SEC source: 0001367644-22-000040 · wf-form4_164626467480687.xml · derivative · entry 4

Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,164

Underlying: Common Stock · 24,164 shares

Expires 2029-02-28

F4 · derivative.exercise_date: Vests in three equal installments beginning on the day prior to the anniversary date of the grant.

SEC source: 0001367644-22-000040 · wf-form4_164626467480687.xml · nonDerivative · entry 2

Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,458

F2 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2022 and ending December 31, 2024, as certified by the Compensation Committee following the performance period. The amount reported is based on the target performance payout factor, or 100%.

SEC source: 0001367644-22-000040 · wf-form4_164626467480687.xml · nonDerivative · entry 1

Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,375

F1 · shares: Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest either in three equal annual installments beginning on the day prior to the first anniversary of the date of grant (6,042 shares) or on the day prior to the second anniversary date of the grant (18,125 shares), assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.